TrialThe Lancet. Oncology2017

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.

David R Freyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.